ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,667.20
      0.64%
      US Tech 100
      19,822.40
      -0.12%
      Dow Jones
      40,954.48
      1.85%
      Brent Oil
      82.975
      -0.41%
      Bitcoin
      65,910.86
      1.26%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. ASLAN Pharmaceuticals Ltd (ASLN)

      7. ASLAN Pharmaceuticals Ltd (ASLN) Financials

      ASLAN Pharmaceuticals Ltd

      ASLAN Pharmaceuticals Ltd (ASLN)

      NASDAQ
      1.11
      -0.27
      (-19.57%)
      Closed July 16 4:00PM
      Delayed by 15 minutes
      1.15
      0.04
      (3.60%)
      After Hours: 7:55PM
      Delayed by 15 minutes

      ASLAN Pharmaceuticals Ltd Financial Summary

      The current ASLN market cap is 3.25M. The company's latest EPS is USD and P/E is N/A.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      TWD (TWD)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 012M000
      Operating Income -18.11M-2.36M-10.42M-12.85M-9.29M
      Net Income -19.11M-1.89M-9.71M-13.51M-9.92M
      Year End December 30 2023 20192020202120222023
      TWD (TWD)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 92.36M00012M
      Operating Income -1.41B-16.48M-34.25M-48.32M-43.74M
      Net Income -1.45B-16.2M-31.59M-51.38M-44.22M

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      TWD (TWD)USD ($)USD ($)USD ($)USD ($)
      Total Assets 60.32M55.21M44.64M24.63M20.99M
      Total Liabilities 50.43M48.84M45.52M37.91M38.95M
      Total Equity 9.89M6.37M-882k-13.29M-17.97M
      Year End December 30 2023 20192020202120222023
      TWD (TWD)USD ($)USD ($)USD ($)USD ($)
      Total Assets 699.39M16.08M94.52M61.19M24.63M
      Total Liabilities 717.46M26.23M37.21M52.82M37.91M
      Total Equity -18.07M-10.15M57.3M8.37M-13.29M

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      TWD (TWD)USD ($)USD ($)USD ($)USD ($)
      Operating N/A -37.33M N/A -46.64M N/A
      Investing N/A 270k N/A 269k N/A
      Financing N/A 21.1M N/A 10.72M N/A
      Year End December 30 2023 20192020202120222023
      TWD (TWD)USD ($)USD ($)USD ($)USD ($)
      Operating -796.12M-15.05M-34M-38.41M-46.64M
      Investing 167k1,000-28k415k269k
      Financing 583.68M7.17M109.87M4.72M10.72M

      Stats and Ratios

      Market Cap 3.25M
      Price to Earnings Ratio N/A
      Price to Sales Ratio 0
      Price to Cash Ratio 0
      Price to Book Ratio 0
      Dividend Yield -

      Share Statistics

      Shares Outstanding 2.83M
      Average Volume (1 week) 0
      Average Volume (1 Month) 0
      52 Week Change -
      52 Week High -
      52 Week Low -
      Spread (Intraday) 0.03 (2.61%)

      Company Info

      Company Name ASLAN Pharmaceuticals Ltd
      Address 190 elgin avenue
      george town 1-9005
      Website https://www.aslanpharma.com
      Industry pharmaceutical preparations (2834)